Corporate Communication,Global Media and Press Releases, Spokesperson European Communication,Communication advisory team. Finance department Leadership and advisory committee.Annual Reports drafting team. Subsidiary Planning and Implementations, PharmaceuticalsAPI and Chemicals Research and development. Countries: EU –UK, Ireland, Poland, Germany, Austria, Romania, Luxomburg, France Africa –Kenya, South Africa, Ghana, Ivory Coast, Senegal Russia & CIS –Moscow,Turkmenistan Specialties: Pharmaceuticals Distribution and Market Launches, Pharma Sales, financial consulting and corporate venture capital. International Corporate Communications and Mass media management. Finance and Accounting: Financial Management with broad experience in all aspects of accounting, tax planning and auditing. Others: Experience in Product Marketing, Pharma Recruitment, Regulatory Submissions, Dossier Preparation, Qualifications and Validations,WHO/GMP Audits,Compliance and RiskAssessment and R&D Documentation.
Shantanu SinghTaj Pharma Latest News & Videos ď‚– Shantanu Kumar Singh is an Indian businessman, Director of Taj Pharma Group India. He serves as a board member for the Pharma Group companies and is responsible for managing the Pharma division growth as a leading health group aground the launched markets.
Shantanu Kumar Singh – Director at Taj Pharma Group and Leading Business Consultant.
Shantanu Kumar Singh – Director at Taj Pharma Group and Leading Business Consultant.
Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business models in the financial capital. He has been recognised by heading Alzheimer’s disease drug trials for the UK market by venturing a new drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia andYemen. Singh attained his education at The Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and Development.
Shantanu Kumar Singh is an Indian businessman, Director of Taj Pharma Group India. He serves as a board member for the Pharma Group companies and is responsible for managing the Pharma division growth as a leading health group aground the launched markets.
Shantanu Singh Taj Pharma Latest News & Videos {Taj Pharma} Shantanu Kumar Singh's Executive Director Taj Pharma Taj Pharmaceuticals Limited Shantanu Singh {Taj Pharma} Shantanu Kumar Singh's Executive Director Taj Pharma Group Shantanu Kumar Singh, TAJ PHARMA - Company directors | Shantanu Kumar Singh is an Indian businessman, Director of Taj Pharma Group India. He serves as a board member for the Pharma Group companies and is responsible for managing the Pharma division growth as a leading health group aground the launched markets. Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business models in the financial capital. He has been recognised by heading Alzheimer disease drug trials for the UK market by venturing a new drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia and Yemen. Singh attained his education at The Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and Development. Specialties: Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning, auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management. Experience | Executive Director “ TAJ PHARMA GROUP Location: Global International Business Operations, Communication and International Conference, Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture handling. Management Strategic Consulting including business plan & international sales strategy development. Corporate Communication, Global Media and Press Releases, Spokesperson European Communication, Communication advisory team. Finance department Leadership and advisory committee
Shantanu Kumar Singh – Director at Taj Pharma Group Specialties: Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning, auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management. Experience Executive Director – TAJ PHARMA GROUP Location: Global International Business Operations, Communication and International Conference, Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture handling. Management Strategic Consulting including business plan & international sales strategy development.
Founder & CEO –TAJ INFOTECH INC. Location: Global Knowledge is Key to today’s Information Age, this is a New Type of I.T. Firm, provides a full range of innovative Web presence products & services to Web Hosts, Web Designers, Technology Consultants and I.T Resellers worldwide. Most innovative cloud technology by our global data centers based in Austin, UK, India and Hong Kong. more: http://shop.tajinfotech.com/
Creative Director – TAJ AGRO Location: Mumbai Area, India Introducing New Products, Business Re-modeling, Business Restructuring, Recovery and turnaround. Director Sales – Taj API Location: Mumbai Area, India Taj Active Pharmaceutical Ingredients (or Taj API) is an international pharmaceutical api company based in India. Taj Api introduced Oseltamivir Phosphate ( INN) which is drug used for H5N1 avian influenza. The company was first to manufacture the raw martial for such a cause in India.
Successful executives are often hailed as superhuman, but the reality is they’re regular people. Well, maybe not exactly!
Successful executives are often hailed as superhuman Executive Director Taj Pharma, Pharmaceuticals, S K Singh Taj Pharma, Shantanu Kumar Singh
Given our unusual lifestyle of an entrepreneur, and that so many are fuelled by the promise of wild riches, it comes as no surprise that we all have an inspiring stories about overcoming adversity. Every business success stories is fraught with an eccentric leader, his personal struggles, and uncommon lifestyles to find their place and translate their life experiences into success. After having some success as a generics formulator, I decided launching a dedicated oncology division to reduce the patient costs. So in 2013 after Completing at Durham University, England; Further pursued a Bachelors and Masters in Indian Law, co-founded an IT firm Taj Infotech INC; one of my most successful endeavors yet which is also fully automated business with very little human intervention. “Prior to founding Taj Infotech, I completed my degrees at Durham”. The extra workload didn’t stop me from innovating in Pharma Sector; I was instrumental in creating some of the first generics into the Russian and African markets. To this day, more than 35 million people all over the world have used one of the company’s products. “Sometimes, the best motivation is not what someone says to you – it’s what you’ve experienced yourself.” Tags: Shantanu kumar Singh executive director director taj Pharmaceuticals | shantanu kumar singh executive director taj pharma | shantanu taj pharma | Successful executives | taj pharma | taj pharmaceutical | taj pharmaceutical director | taj pharmaceutical news | taj pharmaceutical reviews
chemotherapy drugs, Director and CFO, dynamic entrepreneur, Pharmaceuticals, Russia’s pharma, S K Singh Taj Pharma, Shantanu Kumar Singh, taj pharma industry, taj pharma news, Taj Pharmaceuticals Limited, Taj Pharmaceuticals Oncology
Trio of Indian pharmaceutical s millionaires launched 130 oncology generics [Taj Pharma]chemotherapy drugs
ď‚– Owners of Taj Pharmaceuticals have launched 130 innovative oncology to increase patient access their options for chemotherapy drugs
Mr.Shantanu Singh, Abhishek Singh, Priyanka Singh directors of Taj Pharmaceuticals Mumbai
Tags: chemotherapy drugs | Indian pharmaceuticals millionaires | oncology generics | taj pharma | Taj Pharmaceuticals Limited | Trio of Indian pharmaceuticals
This means it is less beholden to local authority funding, which has plummeted in recent years, piling pressure on the wider sector. Taj Pharmaceuticalschemotherapy divisionpaid off a £0.9 million debt five years ago through the sale and leaseback of 2 Oncology care hospitals in Saint Petersburg to a property investment business, Crosswell International, which was backed by private investors at Moscow. Labels: taj oncology, taj pharmaceutical chemotherapy division, taj oncology chemotherapy companies, Chemotherapy drugs—Taj Pharmaceuticals, taj chemotherapy manufacturer, taj pharmaceutical Chemotherapy, taj pharmaceutical Chemotherapy, manufacturers of taj pharmaceuticals oncology, Taj pharmaceuticals chemicals ApiAgro Products, taj pharmaceutical oncology india
Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale in a deal that could net its owners north of £2.5 million.
This same in will lead to a further expansion of newly built Taj Oncology (chemotherapy drugs) Unit based in the Indian Territory; Sources have not confirmed exact details of such new venture; However, the move could be looked at venturing in the regulated markets of oncology products via an EMA, EU GMP regulated infrastructure with Oncology Section — Tablets, Capsules, Liquid and Lyophilized Injectables all under single unit.
Sources confirmed a Press Association report yesterday that the owners of Taj Pharmaceuticals— including Dr.Ranveer Kumar Singh (Chairman), Mr Abhishek Singh (Director), Priyanks Singh and Shantanu Singh (Executive Director)— have mandated investment banks and private equity holders to assess their options, the most likely of which is a sale.
The businessmen own Taj Pharmaceuticals Oncology Unit through their private investment vehicle Singh Investments SPA, and a formal sale process could be kicked off within weeks.
It is thought that several buyers have already expressed an interest, but only offers higher than £2.5 million are being taken seriously.
Dr.Ranvir Kumar Singh and Abhishek Singh (Director) and Priyanks Singh are close associates and have been involved in a number of ventures together, including ownership of a stake in several pharmaceuticals manufacturing units which they sold in 2014.
Trio sibling directors are best known here for their involvement in Russia and CIS markets, mainly, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Uzbekistan. Ms Priyanka Singh is one of the partners behind Russia and CIS front, with more than 500 registered pharmaceutical products in state owned approx 1300– 1800 state owned pharmacies in CIS nations; which gives vast reach to the anti-cancer products and Mr Shantanu Singh for his ownership of national distribution channel cooperation’s “stazs” such based at Saint Petersburg.
Chemotherapy drug patients
Taj Pharmaceuticals Oncology division currently boasts over 20 anti-cancer drug hospitals in Russia and CIS nations that house 11,000 chemotherapy patients people and employ 17,000 staff; who could be in severe drug shortage and budgetary constrains; if such chemotherapy drugs has to be purchased from the open market at retain prices; making such chemotherapy centers to be nonviable for poor and needy patients in India.
Latest accounts filed with Ministry for Economic Developmentof the Russian Federation show that Taj Pharma Russia’s turnover increased 5.3 per cent to £1.9 million in 2016, with operating profit coming in 5.6 per cent higher at £1.3 million.
The Indian pharmaceuticals trio Mr.Abhishek Singh, Mr.Shantanu Singh and Priyanka Singh first invested in Taj Pharmaceuticals Oncology Division in 2004, a year after the company was set up by father Dr Ranvir Singh, and are in line for a bumper payday if a deal goes ahead and a further expansion into bigger and better infrastructure with regulatory approvals.
Its attraction to a potential buyer for old oncology division, likely to be a private equity firm, is the fact that Taj Pharma’s primary focus is on privately-paying residents.